Amgen/Horizon Therapeutics: FTC Staff Probes Buyer’s Past Drug-Price Increases and Alleged Anticompetitive Tactics 

Hewlett Packard Enterprise/Juniper Networks: DOJ Likely to Either Sue or Clear Unconditionally, With No Proposed Remedy on Table; Review Could Extend Past This Week

DOJ will likely either clear unconditionally or sue to block Hewlett Packard Enterprise’s proposed acquisition of rival Juniper Networks and isn’t assessing a proposed remedy to address any...

Merger Monthly: Tapestry/Capri Decision Encouraging for Enforcers Seeking to Build Cases With Documents

U.S. District Judge Jennifer Rochon last month in her Tapestry/Capri decision ever so slightly nudged documents toward the top of the evidence pile. Her reliance on company slide deck presentations,...

Siemens/Altair: Parties’ Deep Chinese Ties, Industry Consolidation Could Trigger SAMR Review; Company Spokesperson Says Deal Should Obtain Clearances

Siemens’s $10.6 billion bid for Altair Engineering could trigger a review by the Chinese antitrust authority due to both companies’ deep business ties to the Asian country and ongoing...